Browsing by Subject "GSK-3β"
Now showing items 1-2 of 2
-
PI3K mediated activation of GSK‑3β reduces at‑level primary afferent growth responses associated with excitotoxic spinal cord injury dysesthesias
(2015-06-21)Background Neuropathic pain and sensory abnormalities are a debilitating secondary consequence of spinal cord injury (SCI). Maladaptive structural plasticity is gaining recognition for its role in contributing to the ... -
Reducing Maladaptive Sensory Neuronal Growth to Target Below-Level Pain Following Spinal Cord Injury
(2015-04-28)Chronic neuropathic pain is a common, debilitating consequence of spinal cord injury (SCI). Up to 94% of the SCI population suffers from SCI pain, with over half reporting it as their worst medical problem. Modern day ...